TET2 and atrial fibrillation: Specifically, TET2 mutations that can occur at any year of age but are most common in individuals above 80 years of age, are likely to influence both CHIP and AF pathogenesis, with CHIP mutations becoming more prevalent with age and found more frequently in patients with AF compared to healthy individuals [109,110].